RecruitingNot ApplicableNCT07805083

Community Enhanced Virtual Informed Consent

Exploring Health Communication Message Factors That Influence Cancer Research Recruitment

Sponsor

Mayo Clinic

Enrollment

600 participants

Start Date

Jul 21, 2026

Study Type

INTERVENTIONAL

Conditions

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Summary

The goal of this clinical trial is to examine perceptions of virtual human communicators and cancer research recruitment messages. This study will also examine how different informed consent approaches influence decisions to participate in research.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Behavioral Intervention, ICF Text Version 1, and others for people with hematopoietic and lymphatic system neoplasm and malignant solid neoplasm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEducational Cancer Intervention

Participants will view informed consent messaging presented in different formats

OTHERICF Text Version 1

Receive a text-based informed consent form

OTHERICF Text Version 2

Receive an adapted text-based informed consent form

OTHERICF Video Version 1

Receive a video-based informed consent form delivered by virtual human #1

OTHERICF Video Version 2

Receive a video-based informed consent form delivered by virtual human #2

OTHERICF Video Version 3

Receive a video-based informed consent form delivered by virtual human #3

OTHERICF Video Version 4

Receive a video-based informed consent form delivered by virtual human #4

OTHERSurvey Administration

Ancillary studies

Locations(1)

Mayo Clinic in Florida

Jacksonville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07805083

Related Trials

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

NCT06126276188 locations

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

NCT04242095625 locations

Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer

NCT071842941 location

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT0381634552 locations

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

NCT061928751 location